{
  "ticker": "JNJ",
  "target_date": "2025-07-21",
  "actual_date": "2025-07-21",
  "collected_at": "2025-12-08T12:02:17.031984",
  "price": {
    "open": 161.55,
    "high": 162.69,
    "low": 160.57,
    "close": 162.13296508789062,
    "volume": 8254000,
    "change_1d_pct": 0.4,
    "change_7d_pct": 4.23,
    "change_30d_pct": 6.96
  },
  "technicals": {
    "rsi_14": 75.86,
    "sma_20": 154.39,
    "sma_50": 152.2,
    "macd": 2.427,
    "macd_signal": 1.448,
    "macd_histogram": 0.979,
    "bb_upper": 162.8,
    "bb_lower": 145.98,
    "price_vs_sma20_pct": 5.02,
    "price_vs_sma50_pct": 6.53,
    "volume_ratio": 0.96
  },
  "fundamentals": {
    "market_cap": 489279651840,
    "pe_ratio": 19.602318,
    "forward_pe": 19.15849,
    "price_to_book": 6.1638393,
    "price_to_sales": 5.309658,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.28,
    "pct_from_52w_low": 44.36
  },
  "macro": {
    "spy": {
      "price": 627.03,
      "change_1d_pct": 0.19,
      "change_7d_pct": 0.83
    },
    "vix": {
      "level": 16.65,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.37
    },
    "dollar_index": {
      "level": 97.85
    },
    "gold": {
      "price": 3401.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ)\u2019s Pasritamig Shows Breakthrough Promise in Prostate Cancer",
      "source": "Yahoo",
      "datetime": 1753136789,
      "summary": "We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Johnson & Johnson stands second among the most undervalued stocks. Johnson & Johnson (NYSE:JNJ) is a global healthcare leader with a diverse portfolio across pharmaceuticals, medical devices, and consumer health. Its Innovative Medi",
      "url": "https://finnhub.io/api/news?id=86b52d248dc5a7945c09602754a297e546ab3bdf5754985a74b1ec50242ccf30"
    },
    {
      "headline": "AstraZeneca announces $50 billion US manufacturing investment, matching its big pharma peers",
      "source": "Yahoo",
      "datetime": 1753133401,
      "summary": "AstraZeneca announces largest ever investment in U.S. manufacturing",
      "url": "https://finnhub.io/api/news?id=655208f1672cea4d00a5215ad51b6c505853d35d1972d8711b057becac987943"
    },
    {
      "headline": "Looking for Cheap Stocks? Healthcare Shares Haven\u2019t Looked This Good in 30 Years.",
      "source": "Yahoo",
      "datetime": 1753116000,
      "summary": "A Goldman ranking of S&P 500 sectors by price/earnings ratios reveals opportunities in healthcare stocks.",
      "url": "https://finnhub.io/api/news?id=cd17fd1452b4268272a9f25932e02fa3a251bf4ddd1b877b3cdb8c32293636a7"
    },
    {
      "headline": "Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?",
      "source": "Yahoo",
      "datetime": 1753112703,
      "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
      "url": "https://finnhub.io/api/news?id=0a8d2b2d09809651f15aec6b5fab1a2db6c58eb88e7ba303d53f62d5432ebced"
    },
    {
      "headline": "Earnings live: Verizon, Domino's kick off busy week for second quarter earnings",
      "source": "Yahoo",
      "datetime": 1753108656,
      "summary": "This week, 112 S&P 500 companies report Q2 results in a busy week for corporate earnings reports.",
      "url": "https://finnhub.io/api/news?id=a2da5556a75afa19f30346c5ac82f368ab7fa38a1124bdffa9d30f3a0dc09830"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760229.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"
    },
    {
      "form": "8-K",
      "date": "2025-06-10",
      "description": "jnj-20250610.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}